Insulin-like growth factor-binding proteins: Functional diversity or redundancy?

Journal of Molecular Endocrinology

Volumn 21, Issue 2, 1998, Pages 97-107

  Murphy, L J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; GROWTH INHIBITION; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RECEPTOR BINDING; REVIEW;

EID: 0031766412     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0210097     Document Type: Review

References (98)

1. Akaogi K, Okabe Y, Funahashi K, Yoshitake Y, Nishikawa K, Yasumitsu H, Umeda M & Miyazaki K 1994 Cell adhesion activity of a 30 kDa major secreted protein from human bladder carcinoma cells. Biochemical and Biophysical Research Communications 198 1046-1053.
2. Angelloz-Nicoud P, Harel L & Binoux M 1996 Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases. Growth Regulation 6 130-136.
3. Arany E, Afford S, Strain AJ, Winwood PJ, Arthur MJ & Hill DJ 1994 Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP1) and IGFBR-3 within human liver. Journal of Clinical Endocrinology and Metabolism 79 1871-1876.
4. Bach LA, Thotakura NR, & Rechler MM 1992 Human insulin-like growth factor binding protein-6 is O-glycosylated. Biochemical and Biophysical Research Communications 186 301-307.
5. Bagley CJ, May BL, Szabo L, McNamara PJ, Ross M, Francis GL, Ballard FJ & Wallace JC 1989 A key functional role for the insulin-like growth factor-I N-terminal pentapeptide. Biochemical Journal 259 665-671.
6. Baldwin S, Chung T, Rogers M, Chard T & Wang HS 1993 Insulin-like growth factor-binding protein-1, glucose tolerance and fetal growth in human pregancy. Journal of Endocrinology 136 319-325.
7. Bang P, Brismar K, Rosenfeld RG & Hall K 1994 Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. Journal of Clinical Endocrinology and Metabolism 78 960-967.
8. Bar RS, Boes M, Clemmons DR, Busby WH, Sandra A, Dake BL & Booth BA 1990 Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in rat heart. Endocrinology 127 497-199.
9. Baxter RC & Cowell CT 1987 Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. Journal of Clinical Endocrinology and Metabolism 65 432-140.
10. Baxter RC & Saunders H 1992 Radioimmunoassay of insulin-like growth factor binding protein-6 in human serum and other body fluids. Journal of Endocrinology 134 133-139.
11. Baxter RC, Holman SR, Corbould A, Stranks S, Ho PJ & Braund W 1995 Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. Journal of Clinical Endocrinology and Metabolism 80 2700-2708.
12. Binoux M, Roghani M, Hossenlopp P & Whitechurch O 1991 Cerebrospinal IGF binding proteins: isolation and characterization. Advances in Experimental Medicine and Biology 293 161-170.
13. Brismar K, Fernqvist-Forbes E, Wahren J & Hall K 1994 Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3 and IGF-I in insulin dependent diabetes. Journal of Clinical Endocrinology and Metabolism 79 872-878.
14. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR & Kley N 1995 Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377 646-649.
15. Busby WH, Snyder DK & Clemmons DR 1988 Radioimmunoassay of a 26 000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables. Journal of Clinical Endocrinology and Metabolism 67 1225-1230.
16. Ceda GP, Fielder PJ, Henzel WJ, Louie A, Donovan SM, Hiffman AR & Rosenfeld RG 1991 Differential effects of insulin-like growth factor (IGF)-I and IGF-II on the expression of IGF binding proteins (IGFBPs) in a rat neuroblastoma cell line: isolation and characterization of two forms of IGFBP-4. Endocrinology 128 2815-2824.
17. Chen Y-G, Liu F & Massague J 1997 Mechanism of TGFβ receptor inhibition by FKBP12. EMBO Journal 13 3866-3876.
18. Cichy SB, Yddin S, Danilkovich A, Guo S, Klippel A & Unterman TG 1998 Protein kinase B/Akt mediates effects of insulin on hepatic insulin-like growth factor-binding protein-1 gene expression through a conserved insulin response sequence. Journal of Biological Chemistry 273 6482-6487.
19. Clemmons DR, Snyder DK & Busby WH 1991 Variables controlling the secretion of insulin-like growth factor binding protein 2 in normal human subjects. Journal of Clinical Endocrinology and Metabolism 73 727-733.
20. Coverley JA & Baxter RC 1997 Phosphorylation of insulin-like growth factor binding proteins. Molecular and Cellular Endocrinology 128 1-5.
21. Daughaday WH & Kapadia M 1989 Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proceedings of the National Academy of Sciences of the USA 86 6778-6782.
22. Daughaday WH, Trivedi B & Baxter RC 1993 Serum 'big insulin-like growth factor II' from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proceedings of the National Academy of Sciences of the USA 90 5823-5827.
23. De Mellow JSM & Baxter RC 1988 Growth hormone dependent insulin-like growth factor binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in human skin fibroblasts. Biochemical and Biophysical Research Communications 156 199-204.
24. Donovan SM & Odle J 1994 Growth factors in milk as mediators of infant development. Annual Review of Nutrition 14 147-167.
25. Donovan SM, Oh Y, Pham H & Rosenfeld RG 1989 Ontogeny of serum insulin-like growth factor binding proteins in the rat. Endocrinology 125 2621-2677.
26. Drop SLS, Valiquette G, Guyda HJ, Corvol MT & Posner BI 1979 Partial purification and characterization of a binding protein for insulin-like activity (ILAs) in human amniotic fluid: a possible inhibitor of insulin-like activity. Acta Endocrinologica 90 505-518.
27. Elgin RG, Busby WH & Clemmons DR 1987 An insulin-like growth factor (IGF) binding protein enhances the biological response to IGF-I. Proceedings of the National Academy of Sciences of the USA 84 3254-3258.
28. Frost RA & Tseng L 1991 Insulin-like growth factor-binding protein-1 is phosphorylated by cultured human endometrial stromal cells and multiple protein kinases in vitro. Journal of Biological Chemistry 266 18082-18088.
29. Frost RA, Fuhrer J, Steigbigel R, Mariuz P, Lang CH & Gelato MC 1996 Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system. Clinical Endocrinology 44 501-514.
30. Frystyk J, Grofte T, Skjaerbaek C & Orskov H 1997 The effect of oral glucose on serum free insulin-like growth factor-I and -II in healthy adults. Journal of Clinical Endocrinology and Metabolism 82 3124-3127.
31. Gleizes PE, Beavis RC, Mazzieri R, Shen B & Rifkin DB 1996 Identification and characterization of an eight-cysteine repeat of the latent transforming growth factor-β binding protein-1 that mediates bonding to the latent transforming growth factor β1. Proceedings of the National Academy of Sciences of the USA 271 29891-29896.
32. Gong Y, Ballejo G, Alkhalaf B, Molnar P, Murphy LC & Murphy LJ 1992 Phorbol esters differentially regulate expression of insulin-like growth factor binding proteins in human endometrial carcinoma cells. Endocrinology 131 2747-2754.
33. Grigoriev VG, Moerman EJ & Goldstein S 1995 Overexpression of insulin-like growth factor binding protein-3 by senescent human fibroblasts: attenuation of the mitogenic response to IGF-I. Experimental Cell Research 219 315-321.
34. Gucev ZS, Oh Y, Kelley KM & Rosenfeld RG 1996 Insulin-like growth factor binding protein 3 mediates retinoic acid and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Cancer Research 56 1545-1550.
35. Guler HP, Zapf J, Schmid C & Froesch ER 1989 Insulin-like growth factors I and II in healthy man. Estimates of half-lives and production rates. Acta Endocrinologica 121 753-758.
36. Han GR, Dohi DF, Lee HY, Rajah R, Walsh GL, Hong WK, Cohen P & Kurie JM 1997 All trans-retinoic acid increases transforming growth factor-beta2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-alpha-dependent signaling pathway. Journal of Biological Chemistry 272 13711-13716.
37. Hasegawa Y, Cohen P, Yorgin P & Rosenfeld RG 1992 Characterization of urinary insulin-like growth factor binding proteins. Journal of Clinical Endocrinology and Metabolism 74 830-835.
38. Hoeck WG & Mukku VR 1994 Identification of the major sites of phosphorylation in IGF binding protein-3. Journal of Cellular Biochemistry 56 262-273.
39. Huynh H & Pollak M 1995 Regulation of IGFBP-3 expression in breast cancer cells and uterus by estradiol and antiestrogens: correlations with effects on proliferation: a review. Progress in Growth Factor Research 6 495-501.
40. Huynh H, Yang X & Pollak M 1996 Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. Journal of Biological Chemistry 271 1016-1021.
41. Jacques G, Noll K, Wegmann B, Witten S, Kogan E, Radulescu RT & Havemann K 1997 Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology 138 1767-1770.
42. Jones JI & Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 16 3-34.
43. Jones JI, Gockerman A, Busby WH, Wright G & Clemmons DR 1993a Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proceedings of the National Academy of Sciences of the USA 90 10553-10557.
44. Jones JI, Gockerman A, Busby WH, Camacho-Hubner C & Clemmons DR 1993b Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. Journal of Cell Biology 121 679-687.
45. Julkunen M, Koistinen R, Aalto-Setala K, Seppala M, Janne OA & Kontula K 1988 Primary structure of human insulin-like growth factor-binding protein/placental protein 12 and tissue-specific expression of its mRNA. FEBS Letters 236 295-302.
46. Karas M, Kleinman D, Danilenko M, Roberts CT, LeRoith D, Levy J & Sharoni Y 1995 Components of the IGF system mediate the opposing effects of tamoxifen on endometrial and breast cancer cell growth. Progress in Growth Factor Research 6 513-520.
47. Kiefer MC, Schmid C, Waldvogel M, Schlapfer I, Futo E, Masiarz FR, Green K, Barr PJ & Zapf J 1992 Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. Journal of Biological Chemistry 267 12692-12699.
48. Kim HS, Nagalla SR, Oh Y, Wilson E, Roberts CT & Rosenfeld RG 1997 Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factors as a member of the IGFBP superfamily. Proceedings of the National Academy of Sciences of the USA 94 12981-12986.
49. Lalou C, Lassarre C & Binoux M 1996 A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137 3206-3212.
50. Lalou C, Sawamura S, Segovia B, Ogawa Y & Binoux M 1997 Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity. Comptes Rendus de l'Académie des Sciences. Serie III, Sciences de la Vie 320 621-628.
51. Leal SM, Liu Q, Huang SS & Huang JS 1997 The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor. Journal of Biological Chemistry 272 20572-20576.
52. Lee PDK, Conover CA & Powell DR 1993 Regulation and function of insulin-like growth factor-binding protein-1. Proceedings of the Society of Experimental Biology and Medicine 204 4-29.
53. Lewitt MS & Baxter RC 1991 Insulin-like growth factor binding protein-1: a role in glucose counterregulation? Molecular and Cellular Endocrinology 79 C147-C152.
54. Lewitt MS, Denyer GS, Cooney GJ & Baxter RC 1992 Insulin-like growth factor binding protein-1 modulates glucose levels. Endocrinology 129 2254-2256.
55. Li W, Fawcett J, Widmer HR, Fielder PJ, Rabkin R & Keller GA 1997 Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. Endocrinology 138 1763-1766.
56. Luo J-M, Reid RE & Murphy LJ 1990 Dexamethasone increases hepatic insulin-like growth factor binding protein-1 (IGFBP-1) mRNA and serum IGFBP-1 concentrations in the rat. Endocrinology 127 1456-1462.
57. Martin JL & Baxter RC 1986 Insulin-like growth factor-binding proteins from human plasma. Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. Journal of Biological Chemistry 261 8754-8760.
58. Martin JL & Baxter RC 1991 Transforming growth factor-β stimulates production of insulin-like growth factor binding protein 3 by human skin fibroblasts. Endocrinology 128 1425-1433.
59. Martin JL, Willetts KE & Baxter RC 1990 Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. Journal of Biological Chemistry 265 4124-4130.
60. Mohan S & Baylink DJ 1996 Insulin-like growth factor (IGF)-binding proteins in serum - do they have additional roles besides modulating the endocrine IGF actions? Journal of Clinical Endocrinology and Metabolism 81 3817-3820.
61. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K & Baylink DJ 1995 Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. Journal of Biological Chemistry 270 22467-22472.
62. Mohseni-Zadeh S & Binoux M 1997 Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action. Endocrinology 138 5645-5648.
63. Murphy LJ, Seneviratne C, Ballejo G, Croze F & Kennedy TG 1990 Identification and characterization of a rat decidual insulin-like growth factor binding protein complementary DNA. Molecular Endocrinology 4 329-336.
64. Murphy LJ, Seneviratne C, Moreira P & Reid R 1991 Enhanced expression insulin-like growth factor binding protein-1 in the fasted rat: the effects of insulin and growth hormone administration. Endocrinology 128 689-696.
65. Murphy LJ, Barron D & Seneviratne C 1993 Hormonal regulation of insulin-like growth factor binding protein-1 expression and the development of transgenic mouse models to study IGFBP-1 function. Advances in Experimental Medicine and Biology 343 279-291.
66. Murphy LJ, Molnar P, Lu X & Huang H 1995 Expression of human insulin-like growth factor binding protein-3 in transgenic mice. Journal of Molecular Endocrinology 15 293-303.
67. Nyomba BLG, Berard L & Murphy LJ 1997 Free insulin-like growth factor-I in healthy subjects: relationship with insulin-like growth factor binding proteins and insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 82 2177-2182.
68. Oh Y, Muller HL, Pham H & Rosenfeld RG 1993 Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. Journal of Biological Chemistry 268 26045-26048.
69. Oh Y, Gucev Z, Ng L, Muller HL & Rosenfeld RG 1995 Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells. Progress in Growth Factor Research 6 205-212.
70. Ooi GT, Orlowski CC, Brown AL, Becker RE, Unterman TG & Rechler MM 1990 Different tissue distribution and hormonal regulation of messenger RNAs encoding rat insulin-like growth factor binding proteins-1 and -2. Molecular Endocrinology 4 321-328.
71. Pintar JE, Schuller A, Bradshaw S, Cerro J & Wood T 1997 Genetic analysis of IGFBP function. Proceedings of the Endocrine Society Meeting, Minneapolis, June 1997, Abstract S49-2. Bethesda, USA: The Endocrine Society.
72. Powell DR 1997 Effects of renal failure on the growth hormone-insulin-like growth factor axis. Journal of Pediatrics 131 S13-S16.
73. Radulescu RT 1994 Nuclear localization signal in insulin-like growth factor-binding protein type 3. Trends in Biochemical Science 19 278-279.
74. Rajah R, Valentinis B & Cohen P 1997 Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53-and IGF-independent mechanism. Journal of Biological Chemistry 272 12181-12188.
75. Rajkumar K, Dheen ST & Murphy LJ 1996 Hyperglycemia and impaired glucose tolerance in insulin-like growth factor binding protein-1 transgenic mice. American Journal of Physiology 270 E565-E571.
76. Rechler MM 1993 Insulin-like growth factor binding proteins. Vitamins and Hormones 46 1-114.
77. Roghani M, Lassarre C, Zapf J, Povoa G & Binoux M 1991 Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins. Journal of Clinical Endocrinology and Metabolism 73 658-666.
78. Romanus JA, Terrell JE, Yang YWH, Nissley SP & Rechler MM 1986 Insulin-like growth factor carrier proteins in neonatal and adult rat serum are immunologically different: demonstration using a new radioimmunoassay for the carrier protein from BRL-3A rat liver cells. Endocrinology 118 1743-1758.
79. Rosenfeld RG 1998 The blind men and the elephant - a parable for the study of insulin-like growth factor binding proteins. Endocrinology 139 5-6.
80. Schmid CH, Rutishauser J, Schlapfer I, Froesch ER & Zapf J 1991 Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF I-induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3-specific proteolysis? Biochemical and Biophysical Research Communications 179 579-585.
81. Shimasaki S & Ling N 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Progress in Growth Factor Research 3 243-266.
82. Suikkari A-M, Koivisto VA, Rutanen E-M, Yki-Jarvinen H, Karonen S-L & Seppala M 1988 Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. Journal of Clinical Endocrinology and Metabolism 66 266-272.
83. Suikkari A-M, Koivisto VA, Koistinen R, Seppala M & Yki-Jarvivnen H 1989a Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. Journal of Clinical Endocrinology and Metabolism 68 135-140.
84. Suikkari A-M, Sane T, Seppala M, Yki-Jarvinen H, Karonen S-L & Koivisto VA 1989b Prolonged exercise increases serum insulin-like growth factor-binding protein concentrations. Journal of Clinical Endocrinology and Metabolism 68 141-144.
85. Suwanickul A, Morris SL & Powell DR 1993 Identification of an insulin-responsive element in the promoter of the human gene for insulin-like growth factor binding protein-1. Journal of Biological Chemistry 268 17063-17068.
86. Swisshelm K, Ryan K, Tsuchuya K & Sager R 1995 Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proceedings of the National Academy of Sciences of the USA 92 4474-4476.
87. Unterman T, Lascon R, Gotway MB, Oehler D, Gounis A, Simmons RA & Ogata ES 1990 Circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) and hepatic mRNA are increased in the small for gestational age (SGA) fetal rat. Endocrinology 127 2035-2037.
88. Valentinis B, Bhala A, DeAngelis T, Baserga R & Cohen P 1996 The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Molecular Endocrinology 9 361-367.
89. Velez-Yanguas MC, Kalebic T, Maggi M, Kappel CC, Letterio J, Uskokovic M & Helman LJ 1996 1 alpha, 25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531) modulation of insulin-like growth factor-binding protein-3 and induction of differentiation and growth arrest in a human osteosarcoma cell line. Journal of Clinical Endocrinology and Metabolism 81 93-99.
90. Wood TL, Rogler L, Streck RD, Cerro J, Green B, Grewal A & Pintar JE 1993 Targeted disruption of IGFBP-2 gene. Growth Regulation 8 5-8.
91. Wood WI, Cachianes G, Henzel WJ, Winslow GA, Spencer SA, Hellmiss R, Martin JL & Baxter RC 1988 Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Molecular Endocrinology 2 1176-1182.
92. Yamamoto H & Murphy LJ 1994 Generation of des (1-3) insulin-like growth factor-I in serum by an acid protease. Endocrinology 135 2432-2440.
93. Yamanaka Y, Wilson EM, Rosenfeld RG & Oh Y 1997 Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. Journal of Biological Chemistry 272 30729-30734.
94. Yamauchi T, Umeda F, Masakado M, Isaji M, Mizushima S & Nawata H 1994 Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochemical Journal 303 591-598.
95. Zadeh SM & Binoux M 1997 The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. Endocrinology 138 3069-3072.
96. Zapf J 1994 Role of insulin-like growth factor II and IGF binding proteins in extrapancreatic tumor hypoglycemia. Hormone Research 42 20-26.
97. Zapf J, Hauri C, Waldvogel M, Futo E, Hasler H, Benz K, Guler HP, Schmid C & Froesch ER 1989 Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proceedings of the National Academy of Sciences of the USA 86 3813-3817.
98. Zapf J, Schmid C, Guler HP, Waldvogel M, Hauri C, Futo E, Hossenlopp P, Binoux M & Froesch ER 1990 Regulation of binding proteins for insulin-like growth factor (IGF) in humans. Journal of Clinical Investigation 86 952-961.